CEFTAZIDIME TAMRISA 1 g, poudre pour solution injectable (IM,IV) — 10 flacon(s) en verre

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400957041601
  • CIP7 5704160
  • CIS 67734097

What the source publishes

Holder
TAMRISA ACCESS (FRANCE)
Active ingredients
CEFTAZIDIME PENTAHYDRATÉE, CEFTAZIDIME ANHYDRE
Form
poudre pour solution injectable
Package
10 flacon(s) en verre
Routes
intramusculaire, intraveineuse
Administrative status
authorised
Supply regime
prescription hospitalière ; liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2006-12-18
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400957041601
{
  "cis": "67734097",
  "cip7": "5704160",
  "form": "poudre pour solution injectable",
  "name": "CEFTAZIDIME TAMRISA 1 g, poudre pour solution injectable (IM,IV) — 10 flacon(s) en verre",
  "cip13": "3400957041601",
  "holder": "TAMRISA ACCESS (FRANCE)",
  "routes": [
    "intramusculaire",
    "intraveineuse"
  ],
  "holders": [
    "TAMRISA ACCESS (FRANCE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2006-12-18",
  "compositions": [
    {
      "name": "CEFTAZIDIME PENTAHYDRATÉE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "01316",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "CEFTAZIDIME ANHYDRE",
      "nature": "FT",
      "strength": "1 g",
      "linkageNumber": "1",
      "substanceCode": "49416",
      "dosageReference": "un flacon de poudre",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription hospitalière ; liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CEFTAZIDIME TAMRISA 1 g, poudre pour solution injectable (IM,IV)",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "10 flacon(s) en verre",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-09-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CEFTAZIDIME PENTAHYDRATÉE",
    "CEFTAZIDIME ANHYDRE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400957041601"